Stay updated on PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange Detected- Revision updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedAdded Marinesco-Sjögren syndrome and a Genetic and Rare Diseases Information Center resources entry to the page.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision updated to v3.5.0 and removal of v3.4.3.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check75 days agoChange DetectedAdded Revision: v3.4.2. Removed the government funding lapse notice and Revision: v3.4.1 banner.SummaryDifference0.4%

- Check82 days agoChange DetectedAdded a banner about government funding status and updated the page revision to v3.4.1, replacing the previous v3.4.0 revision note.SummaryDifference0.4%

Stay in the know with updates to PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial page.